Sexual Behavior Patterns and PrEP Dosing Preferences in a Large Sample of North American Men Who Have Sex with Men

Journal of Acquired Immune Deficiency Syndromes

Volumn 71, Issue 1, 2016, Pages 94-101

  Stack, Conor ^a   Oldenburg, Catie ^b   Mimiaga, Matthew ^c,d   Elsesser, Steven A ^c,e   Krakower, Douglas ^a,d   Novak, David S ^f   Egan, James E ^g   Stall, Ronald ^g   Safren, Steve ^d,h   Mayer, Kenneth H ^d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c BROWN UNIVERSITY   (United States)

^d FENWAY INSTITUTE   (United States)

^e THOMAS JEFFERSON UNIVERSITY   (United States)

^f On Line Buddies   (United States)

^g UNIVERSITY OF PITTSBURGH   (United States)

^h University of Miami   (United States)

Author keywords

HIV prevention; intermittent PrEP; PrEP

Indexed keywords

ADULT; ANAL INTERCOURSE; ARTICLE; BISEXUALITY; CONDOMLESS ANAL INTERCOURSE; EDUCATIONAL STATUS; HOMOSEXUAL MALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCOME; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MEN WHO HAVE SEX WITH MEN; MONOGAMY; NORTH AMERICAN; ONLINE SYSTEM; PRE-EXPOSURE PROPHYLAXIS; PRIORITY JOURNAL; SELF CONCEPT; SEXUAL BEHAVIOR; ATTITUDE TO HEALTH; HIV INFECTIONS; MALE HOMOSEXUALITY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT ATTITUDE; PROCEDURES; PSYCHOLOGY; RISK FACTOR; SEXUALITY; STATISTICS AND NUMERICAL DATA; UNITED STATES; UNSAFE SEX; YOUNG ADULT;

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ANTI-HIV AGENTS; EDUCATIONAL STATUS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT ACCEPTANCE OF HEALTH CARE; PRE-EXPOSURE PROPHYLAXIS; RISK FACTORS; SEXUAL PARTNERS; UNITED STATES; UNSAFE SEX; YOUNG ADULT;

EID: 84983158091     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000816     Document Type: Article

References (43)

1. Beyrer C, Baral SD, van Griensven F, et al. Global epidemiology of HIV infection in men who have sex with men. Lancet. 2012;380: 367-377.
2. Beyrer C, Sullivan P, Sanchez J, et al. The increase in global HIV epidemics in MSM. AIDS. 2013;27:2665-2678.
3. Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010; 363:2587-2599.
4. Baeten JM, Donnell D, Ndase P, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367: 399-410.
5. Thigpen MC, Kebaabetswe PM, Paxton LA, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012;367:423-434.
6. Choopanya K, Martin M, Suntharasamai P, et al. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebocontrolled phase 3 trial. Lancet. 2013;381:2083-2090.
7. Van Damme L, Corneli A, Ahmed K, et al. Preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2012;367:411-422.
8. Marrazzo JM, Ramjee G, Richardson BA, et al. Tenofovir-based preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2015;372:509-518.
9. Baeten J, Celum C. Systemic and topical drugs for the prevention of HIV infection: antiretroviral pre-exposure prophylaxis. Annu Rev Med. 2013; 64:219-232.
10. Anderson PL, Glidden DV, Liu A, et al. Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Sci Transl Med. 2012;4:151ra125.
11. Centers for Disease Control and Prevention (CDC). Interim guidance: preexposure prophylaxis for the prevention of HIV infection in men who have sex with men. MMWR Morb Mortal Wkly Rep. 2011;60:65-68. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6003a1.htm. Accessed June 12, 2014.
12. Centers for Disease Control and Prevention (CDC). Interim guidance for clinicians considering the use of preexposure prophylaxis for the prevention of HIV infection in heterosexually active adults. MMWR Morb Mortal Wkly Rep. 2012;61:586-589. Available at: http://www.cdc. gov/mmwr/preview/mmwrhtml/mm6131a2.htm. Accessed June 12, 2014.
13. Krakower D, Mayer KH. Engaging healthcare providers to implement HIV pre-exposure prophylaxis. Curr Opin HIV AIDS. 2012;7:593-599.
14. Brooks RA, Kaplan RL, Lieber E, et al. Motivators, concerns, and barriers to adoption of preexposure prophylaxis for HIV prevention among gay and bisexual men in HIV-serodiscordant male relationships. AIDS Care. 2011;23:1136-1145.
15. Krakower D, Ware N, Mitty JA, et al. HIV providers' perceived barriers and facilitators to implementing pre-exposure prophylaxis in care settings: a qualitative study. AIDS Behav. 2014;18:1712-1721.
16. Molina JM, Pintado C, Gatey C, et al. Challenges and opportunities for oral pre-exposure prophylaxis in the prevention of HIV infection: where are we in Europe? BMC Med. 2013;11:186.
17. Abdool Karim Q, Abdool Karim SS, Frohlich JA, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010;329:1168-1174.
18. FACTS 001 trial: questions and answers. Available at: http://www.usaid.gov/sites/default/files/documents/1864/FACTS-001.pdf. Accessed June 18, 2015.
19. ANRS (Agence nationale de recherches sur le sida et les hépatites virales). Available at: http://www.ipergay.fr/. Accessed June 12, 2014.
20. Press release: a significant breakthrough in the fight agains HIV/AIDS. Available at: www.avac.org/sites/default/files/u44/ipergayPR.pdf. Accessed May 1, 2015.
21. Molina JM, Capitant C, Charreau I, et al. On demand PrEP with oral TDF-FTC in MSM: results of the ANRS Ipergay trial [abstract 23LB]. Paper presented at: Conference on Retroviruses and Opportunistic Infections 2015; February 23-26, 2015; Seattle, WA. CROI, 2015. Available at: http://www.croiconference.org/sessions/demand-preporal-tdf-ftc-msm-results-Anrs-ipergay-trial. Accessed June 18, 2015.
22. HIV Prevention Trials Network. Available at: http://www.hptn.org/. Accessed June 12, 2014.
23. HPTN 067/ADAPT Study. Results brief on daily vs. non-daily PrEP dosing regimens for South African women. Available at: http://www. hptn.org/web%20documents/HPTN067/HPTN067-SAresults-Fact% 20Sheet-V1.0.pdf. Accessed March 3, 2015.
24. HPTN 067-The Adapt Study. A phase II, randomized, open-label, pharmacokinetic and behavioral study of the use of intermittent oral emtricitabine/tenofovir disoproxil fumarate pre-exposure prophylaxis (PrEP). Available at: http://www.hptn.org/research-studies/hptn067.asp. Accessed March 3, 2015.
25. Prejean J, Song R, Hernandez A, et al. Estimated HIV incidence in the United States, 2006-2009. PLoS One. 2011;6:e17502.
26. McFarlane M, Bull SS, Rietmeijer CA. The internet as a newly emerging risk environment for sexually transmitted diseases. JAMA. 2000;284: 443-446.
27. Tashima KT, Alt EN, Harwell JI, et al. Internet sex-seeking leads to acute HIV infection: a report of two cases. Int J STD AIDS. 2003;14:285-286.
28. Rosser BR, Oakes JM, Horvath KJ, et al. HIV sexual risk behavior by men who use the Internet to seek sex with men: results of the Men's INTernet Sex Study-II (MINTS-II). AIDS Behav. 2009;13:488-498.
29. Krakower DS, Mimiaga MJ, Rosenberger JG, et al. Limited awareness and low immediate uptake of pre-exposure prophylaxis among men who have sex with men using an internet social networking site. PLoS One. 2012;7:e33119.
30. Ewing JA. Detecting alcoholism. The CAGE questionnaire. JAMA. 1984; 252:1905-1907.
31. Knowlton R, McCusker J, Stoddard A, et al. The use of the CAGE questionnaire in a cohort of homosexually active men. J Stud Alcohol. 1994;55:692-694.
32. Andresen EM, Malmgren JA, Carter WB, et al. Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale). Am J Prev Med. 1994;10: 77-84.
33. Mimiaga MJ, Goldhammer H, Belanoff C, et al. Men who have sex with men: perceptions about sexual risk, HIV and sexually transmitted disease testing, and provider communication. Sex Transm Dis. 2007; 34:113-119.
34. van Griensven F, Thienkrua W, Sukwicha W, et al. Sex frequency and sex planning among men who have sex with men in Bangkok, Thailand: implications for pre-And post-exposure prophylaxis against HIV infection. J Int AIDS Soc. 2010;13:13.
35. Volk JE, Liu A, Vittinghoff E, et al. Sexual frequency and planning among at-risk men who have sex with men in the United States: implications for event-based intermittent pre-exposure prophylaxis. J Acquir Immune Defic Syndr. 2012;61:112-115.
36. Van der Elst EM, Mbogua J, Operario D, et al. High acceptability of HIV pre-exposure prophylaxis but challenges in adherence and use: qualitative insights from a phase I trial of intermittent and daily PrEP in at-risk populations in Kenya. AIDS Behav. 2013;17:2162-2172.
37. Kibengo FM, Ruzagira E, Katende D, et al. Safety, adherence and acceptability of intermittent tenofovir/emtricitabine as HIV pre-exposure prophylaxis (PrEP) among HIV-uninfected Ugandan volunteers living in HIV-serodiscordant relationships: a randomized, clinical trial. PLoS One. 2013;8:e74314.
38. Eisingerich AB, Wheelock A, Gomez GB, et al. Attitudes and acceptance of oral and parenteral HIV preexposure prophylaxis among potential user groups: a multinational study. PLoS One. 2012;7:e28238.
39. Mutua G, Sanders E, Mugo P, et al. Safety and adherence to intermittent pre-exposure prophylaxis (PrEP) for HIV-1 in African men who have sex with men and female sex workers. PLoS One. 2012;7:e33103.
40. Roberts ST, Heffron R, Ngure K, et al. Preferences for daily or intermittent pre-exposure prophylaxis regimens and ability to anticipate sex among HIV uninfected members of Kenyan HIV serodiscordant couples. AIDS Behav. 2014;18:1701-1711.
41. Weatherburn P, Schmidt A, Hickson F, et al. The European men-whohave-sex-WithMen internet survey (EMIS): design and methods. Sex Res Soc Policy. 2013;10:243-257.
42. Metzger DS, Koblin B, Turner C, et al. Randomized controlled trial of audio computer-Assisted self-interviewing: utility and acceptability in longitudinal studies. HIVNET Vaccine Preparedness Study Protocol Team. Am J Epidemiol. 2000;152:99-106.
43. Ellen JM, Gurvey JE, Pasch L, et al. A randomized comparison of A-CASI and phone interviews to assess STD/HIV-related risk behaviors in teens. J Adolesc Health. 2002;31:26-30.